PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAddex Therapeutics
Addex Therapeutics(ADXN)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fluorodopa f-18
renal cell carcinoma
,
carcinoma
,
prostatic neoplasms
,
heart failure
,
cardiomyopathies
,
sudden death cardiac
,
breast neoplasms
,
neuroendocrine tumors
Dipraglurant
healthy volunteers/patients
,
dystonic disorders
,
dystonia
,
blepharospasm
,
parkinson disease
,
dyskinesias
,
drug-induced dyskinesia
Glutamic acid
schizophrenia
,
psychotic disorders
RASEGLURANT
gastroesophageal reflux
,
peptic esophagitis
,
migraine disorders
D-glutamate
schizophrenia
,
psychotic disorders
Fludeoxyglucose f-18
type 2 diabetes mellitus
,
diabetes mellitus
,
healthy volunteers/patients
,
cardiomyopathies
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
type 1 diabetes mellitus
,
tobacco use disorder
,
hyperlipidemias
,
chronic obstructive pulmonary disease
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use